Skip to main content

Table 1 Baseline characteristics of subjects included in the analysis

From: Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial

  Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
Number of participants (n = 39) 10 9 5 5 5 5
Sex
 Male 3 (30%) 2 (22%) 2 (40%) 3 (60%) 2 (40%) 5 (100%)
 Female 7 (70%) 7 (78%) 3 (60%) 2 (40%) 3 (60%) 0 (0%)
Age, years 21.5 (1.8) 21.1 (2.6) 22.4 (1.6) 20.1 (1.3) 20.4 (2.5) 22.6 (3.1)
Body mass index, kg/m2 21.8 (2.3) 21.4 (1.7) 22.0 (3.1) 20.6 (2.0) 24.8 (3.3) 23.2 (1.7)
P. falciparum strain
 Immunization NF54 NF54 NF54 Uninfected Uninfected Uninfected
 Challenge NF135.C10 NF166.C8 NF54 NF135.C10 NF166.C8 NF54
  1. Data are n (%), mean (SD)